IRIS
BUTTINI, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.071
AS - Asia 4.454
EU - Europa 3.642
SA - Sud America 734
AF - Africa 201
OC - Oceania 32
Continente sconosciuto - Info sul continente non disponibili 6
Totale 14.140
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.942
SG - Singapore 1.802
CN - Cina 1.391
IT - Italia 753
IE - Irlanda 724
BR - Brasile 597
SE - Svezia 480
HK - Hong Kong 401
FI - Finlandia 374
DE - Germania 337
VN - Vietnam 316
NL - Olanda 215
FR - Francia 156
TR - Turchia 154
ZA - Sudafrica 154
UA - Ucraina 137
GB - Regno Unito 119
RU - Federazione Russa 96
CA - Canada 76
IN - India 76
AT - Austria 75
AR - Argentina 73
KR - Corea 68
BD - Bangladesh 53
ES - Italia 39
ID - Indonesia 39
JP - Giappone 37
MX - Messico 37
BE - Belgio 28
PL - Polonia 26
AU - Australia 24
IQ - Iraq 21
EC - Ecuador 20
CZ - Repubblica Ceca 18
PK - Pakistan 14
CI - Costa d'Avorio 13
MA - Marocco 13
PY - Paraguay 13
RS - Serbia 12
CO - Colombia 11
UZ - Uzbekistan 11
PT - Portogallo 9
TW - Taiwan 9
CL - Cile 8
KE - Kenya 8
LT - Lituania 8
MY - Malesia 8
NZ - Nuova Zelanda 8
AE - Emirati Arabi Uniti 7
HU - Ungheria 6
IR - Iran 6
AZ - Azerbaigian 5
BO - Bolivia 5
EU - Europa 5
JO - Giordania 5
VE - Venezuela 5
CH - Svizzera 4
JM - Giamaica 4
KZ - Kazakistan 4
TH - Thailandia 4
CR - Costa Rica 3
EE - Estonia 3
HR - Croazia 3
PA - Panama 3
PS - Palestinian Territory 3
QA - Qatar 3
RO - Romania 3
TN - Tunisia 3
AL - Albania 2
BH - Bahrain 2
BY - Bielorussia 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
IL - Israele 2
LB - Libano 2
LU - Lussemburgo 2
MK - Macedonia 2
NO - Norvegia 2
OM - Oman 2
PE - Perù 2
SA - Arabia Saudita 2
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
Totale 14.133
Salva come PNG Salva come JPEG
Città #
Singapore 916
Dublin 717
Ashburn 713
Chandler 627
Santa Clara 414
Hong Kong 400
Dallas 394
Beijing 354
Dearborn 220
Parma 219
Boardman 188
Jacksonville 163
Ann Arbor 150
Johannesburg 148
Nanjing 147
Princeton 116
Shanghai 113
Ho Chi Minh City 109
Izmir 107
Munich 104
Los Angeles 100
Hefei 97
Wilmington 92
Milan 73
Hanoi 70
Columbus 67
Seoul 65
Helsinki 64
Moscow 63
New York 59
Vienna 55
São Paulo 52
Bremen 46
Seattle 42
Shenyang 42
San Mateo 41
Bologna 39
Chicago 38
Nanchang 38
Turku 36
Buffalo 35
The Dalles 34
Changsha 33
Groningen 33
Kunming 32
London 31
Woodbridge 31
Council Bluffs 30
Hebei 30
Jiaxing 30
Guangzhou 29
Tianjin 28
Jakarta 27
Brooklyn 26
Des Moines 26
Rome 26
Toronto 26
Brussels 25
Houston 25
Jinan 25
Frankfurt am Main 24
Marseille 24
San Jose 24
Falls Church 23
Reggio Emilia 23
Stockholm 22
Tokyo 22
Warsaw 22
Ardea 20
Sydney 20
Montreal 19
Amsterdam 18
Ferrara 18
Norwalk 17
Pune 16
Rio de Janeiro 16
Fremont 15
Haiphong 15
Istanbul 15
Mexico City 15
Phoenix 15
Atlanta 14
Chennai 14
Da Nang 14
Abidjan 13
Grafing 13
Kocaeli 13
Porto Alegre 13
San Francisco 13
Manchester 12
Nuremberg 12
Orem 12
Belo Horizonte 11
Brno 11
Bắc Ninh 11
Düsseldorf 11
Formigine 11
Padova 11
Denver 10
Hangzhou 10
Totale 8.712
Salva come PNG Salva come JPEG
Nome #
Excipient-free pulmonary insulin dry powder: Pharmacokinetic and pharmacodynamics profiles in rats 222
Development of inhalation powders containing lactic acid bacteria with antimicrobial activity against Pseudomonas aeruginosa 190
Nano-adjuvanted dry powder vaccine for the mucosal immunization against airways pathogens 184
Opportunity and challenges of nasal powders: Drug formulation and delivery 179
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease 167
Inhalable microparticles embedding calcium phosphate nanoparticles for heart targeting: The formulation experimental design 164
CHIMERAL AGGLOMERATES OF MICRONIZED POWDER FOR NASAL ADMINISTRATION OF ANALGESIC DRUG 160
Nebulizers effectiveness on pulmonary delivery of alpha-1 antitrypsin 154
Solid-state characterization of tobramycin powders for inhalation 152
An Enhanced Dissolving Cyclosporin-A Inhalable Powder Efficiently Reduces SARS-CoV-2 Infection In Vitro 148
Chimeral agglomerates of microparticles for the administration of caffeine nasal powders 147
Consequences of not-shaking and shake-fire delays on the emitted dose of some commercial solution and suspension pressurized metered dose inhalers 146
Agglomerates of Morphine Microcrystals for Nasal or Buccal Administration 143
The Impact of Possible Misuses Conditions on in Vitro Performance of NEXThaler in Comparison with Ellipta Inhaler 141
Accessorized DPI: a Shortcut towards Flexibility and Patient Adaptability in Dry Powder Inhalation 141
A respirable HPV-L2 dry-powder vaccine with GLA as amphiphilic lubricant and immune-adjuvant 139
Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction 138
Aerosolization performance of jet nebulizers and biopharmaceutical aspects 136
Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients 133
Crystalline Microparticles of a Beta-Agonist Coated with a Fatty Acid 131
Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers 131
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections 130
High shear mixing of lactose and salmeterol xinafoate dry powder blends: biopharmaceutic and aerodynamic performances 129
A DRUG POWDER FOR INHALATION ADMINISTRATION AND PROCESS THEREOF 128
A Clinical Study of a Methacholine Dry Powder for the Bronchial Challenge Test 127
Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting 126
The use of multilayer poly(vinyl alcohol) adsorption to fabricate drug rich inhalable microparticles. 125
"Pierce and inhale" design in capsule based dry powder inhalers: Effect of capsule piercing and motion on aerodynamic performance of drugs 125
Caratterizzazione e modellazione del comportamento meccanicodella valvola di un pMDI. 125
Therapeutic effect of cyclosporine A-loading TPGS micelles on a mouse model of LPS-induced neuroinflammation 124
Engineered sodium hyaluronate respirable dry powders for pulmonary drug delivery 124
Crystallization of stable doped mannitol polymorphs and in vitro assessment of their safety as carriers for lung delivery 124
Chimeral agglomerates of microparticles for nasal administration of analgesic drug powders 123
Cyclosporine A micellar nasal spray characterization and antiviral action against SARS-CoV-2 123
Dose administration manoeuvres and patient care in tobramycin dry powder inhalation therapy 121
Respicell(TM): An innovative dissolution apparatus for inhaled products 119
Microparticles comprising a salt of 8-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone having improved adhesion properties for dry powder inhalation 118
Carrageenan from red algae: an application in the development of inhalable tuberculosis therapy targeting the macrophages 118
Design and Characterization of Maltoheptaose-b-Polystyrene Nanoparticles, as a Potential New Nanocarrier for Oral Delivery of Tamoxifen 117
Mannitol polymorphs as carrier in dpis formulations: Isolation characterization and performance 115
A dry powder formulation for peripheral lung delivery and absorption of an anti-SARS-CoV-2 ACE2 decoy polypeptide 113
Nebulized coenzyme Q10 nanosuspensions: A versatile approach for pulmonary antioxidant therapy 113
Nasal delivery as a strategy for the prevention and treatment of COVID-19 112
Clinically Relevant Characterization and Comparison of Ryaltris and Other Anti-Allergic Nasal Sprays 111
Respirable amikacin dry powders for inhalation by a Quality bu Design procedure 111
Characterisation of Particles Emitted from Two Formulations of Beclomethasone Dipropionate Solution Metered Dose Inhalers 111
Pulmonary Spray Dried Powders of Tobramycin Containing Sodium Stearate to Improve Aerosolization Efficiency 110
Lung-to-Heart Nano-in-Micro Peptide Promotes Cardiac Recovery in a Pig Model of Chronic Heart Failure 109
Layered lipid microcapsules for mesalazine delayed-release in children 107
Compositions in powder form made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 107
Esomeprazole immediate release tablets: Gastric mucosa ex vivo permeation, absorption and antisecretory activity in conscious rats 106
Dry Coating Technique for Inhalation Powders 106
Complex product composition generates risks for generic substitution also with dosage forms for intravenous administration 105
Evaluation of the Physico-mechanical Properties and Electrostatic Charging Behavior of Different Capsule Types for Inhalation Under Distinct Environmental Conditions 105
The role of lipophilic adjuvant to produce high respirable tobramicin powders for inhalation 105
The development of amikacin dry powder for pulmonary administration 104
The role of airways microbiota on local and systemic diseases: a rationale for probiotics delivery to the respiratory tract 103
Polysaccharides: New Frontiers for Nasal Administration of Medicines 103
Back to Basics: The development of a simple, homogenous, two-component dry powder inhaler formulation for the delivery of budesonide using miscible vinyl polymers. 103
The application of Quality by Design framework in the pharmaceutical development of dry powder inhalers 102
Dry powder inhalation technology for heart targeting applied to calcium phosphate nanoparticles loaded with active substances 101
Sodium Hyaluronate Microparticles for Pulmonary Delivery of Anti-mycobacterial Drugs 101
POLVERI NASALI DI MORFINA PER UNA RAPIDA ANALGESIA 101
Compositions in powder from made of soft agglomerates of a micronized drug and of a two-components excipient, and process for their preparation 100
Formulation Strategies for Antitubercular Drugs by Inhalation 100
Performance of Different Nebulizers in the Aerosolization of Colistimethate Sodium 100
Particles comprising a salt of 8-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino] ethyl]-2(1h)-quinolinone having improved adhesion properties for powder formulations for inhalation 99
Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler® in Comparison with Diskus® and Turbohaler® Dry Powder Inhalers 99
Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect 98
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs 97
Ex vivo permeation of tamoxifen and its 4-OH metabolite through rat intestine from lecithin/chitosan nanoparticles 97
Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the in Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler 97
Aerodynamic assessment for inhalation products: fundamentals and current pharmacopoeial methods 97
High Respirable Insulin Dry Powder for Pulmonary Administration 96
Particles and powders: Tools of innovation for non-invasive drug administration 95
Spray dried amikacin powder for inhalation in cystic fibrosis patients: A quality by design approach for product construction 95
The impact of lipid corona on rifampicin intramacrophagic transport using inhaled solid lipid nanoparticles surface-decorated with a mannosylated surfactant 95
The role of the solid state and physical properties of the carrier in adhesive mixtures for lung delivery 94
Resistant tuberculosis: The latest advancements of second-line antibiotic inhalation products 94
Lecithin/chitosan controlled release nanopreparations of tamoxifen citrate: Loading, enzyme-trigger release and cell uptake 93
Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation 93
Inhalable spray-dried chondroitin sulphate microparticles: Effect of different solvents on particle properties and drug activity 92
Dry powders for the inhalation of ciprofloxacin or levofloxacin combined with a mucolytic agent for cystic fibrosis patients 92
Effect of polymers for aerolization properties of mannitol-based microcomposites containing meloxicam 91
Drug Delivery Strategies for Pulmonary Administration of Antibiotics 91
The Influence of Energy Input During Dry Powder Blending on Dynamic Flow Properties, Powder Aerosolization and Dissolution of Dry Powders for Inhalation 91
Hybrid Nanoparticles as a Novel Tool for Regulating Psychosine-Induced Neuroinflammation and Demyelination In Vitro and Ex vivo 91
No-shaking and shake-fire delays affect respirable dose for suspension but not solution pMDIs (vol 631, 122478, 2023) 90
100 years of drug delivery to the lungs 90
AEROSOLIZED SULFATED HYALURONAN DERIVATIVES PROLONG THE SURVIVAL OF K18 ACE2 MICE INFECTED WITH A LETHAL DOSE OF SARS-COV-2 89
chimerical agglomerates of microparticles for nasal administration of analgesic drug powders 89
Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations 89
Multilayer PVA adsorption onto hydrophobic drug substrates to engineer drug-rich microparticles 88
Novel Dry Hyaluronic Acid–Vancomycin Complex Powder for Inhalation, Useful in Pulmonary Infections Associated with Cystic Fibrosis 88
Nasal inhalation of antiviral microparticulate powders to target early infection of upper airways 87
Micro/nanosystems and biomaterials for controlled delivery of antimicrobial and anti-biofilm agents 87
INHALATION DRUG DELIVERY Techniques and Products 87
Influence of Sodium Stearate on Amikacin Dry Powder Inhaler for the Treatment of Cystic Fibrosis Patients with Pseudomonas Aeruginosa Lung Infections 86
Nanostructures for overcoming the pulmonary barrier: drug delivery strategies 85
Nasal Powders of Morphine Microcrystal Agglomerates 84
Totale 11.462
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.355
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021379 0 0 0 0 0 44 90 39 92 36 55 23
2021/2022591 12 7 14 32 37 36 64 58 38 39 19 235
2022/20232.342 244 218 132 186 175 254 29 166 774 31 97 36
2023/20241.220 56 79 24 60 93 205 222 89 34 87 111 160
2024/20253.505 88 184 223 292 305 386 195 150 385 347 295 655
2025/20264.139 611 647 949 662 1.013 257 0 0 0 0 0 0
Totale 14.424